Seres Therapeutics (MCRB) – Market Performance Update
- Price movement: Shares of Seres Therapeutics closed at USD 2.31 on Wednesday, 21 Oct 2026, reflecting a decline of –4.55 % during the 24‑hour period ending at 02:33 PM Central Europe.
- Trading volume: In the last 24 hours, USD 154.3 k worth of shares were traded.
- Outstanding shares: The company has 10 million shares available for trading.
- Market capitalization: At the current price, the market cap is USD 24.3 million.
- Historical trend: Since the end of the previous month, the share price has fallen by –43.24 %.
- Moving average: The 200‑day simple moving average stands at USD 7.65.
- 52‑week range: The highest price reached USD 29.98 on 20 Nov 2025; the lowest price was USD 2.31 on 20 Oct 2026.
Comparison with Peer Companies (24‑Hour Performance)
| Ticker | Current price (USD) | % change | Market cap (USD) | Notable corporate action |
|---|---|---|---|---|
| WKHS | 2.65 | –0.38 % | 29.1 mn | — |
| OPNW | 1.98 | –8.76 % | 29.1 mn | Completed legal name change to OpenWorld; declared dividend of 1.50 USD per share. |
| CVM | 1.55 | –6.06 % | 29 mn | — |
| RNAZ | 1.68 | –1.18 % | 28.8 mn | — |
| BSEM | 1.64 | +6.49 % | 28.6 mn | — |
Company Overview
Seres Therapeutics, Inc. is headquartered in Cambridge, Massachusetts. The company focuses on the development of biological drugs that restore health by correcting dysbiotic microbiomes and conducts research into metabolic diseases. It is listed on the Nasdaq stock exchange and completed its initial public offering on 26 June 2015. Further information is available on the company’s website, www.serestherapeutics.com .
